Hexahydronaphth(1,2-b)-1,4-oxazines, process for their preparation and pharmaceutical formulation containing them
申请人:Merck & Co., Inc.
公开号:EP0080115A2
公开(公告)日:1983-06-01
Hexahydronaphth[1,2-b]-1,4-oxazines have dopaminergic activity and display α2-adrenergic receptor antagonism. They are useful in the treatment of parkinsonism, depression and hypertension. An important method of preparation is by ring closure of the appropriate 2-chloroacetamido- tetrahydronaphthalen-1-ol and reduction of the resulting cyclic amide carbonyl group.
Synthesis of 4-substituted 2H-naphth[1,2-b]-1,4-oxazines, a new class of dopamine agonists
作者:James H. Jones、Paul S. Anderson、John J. Baldwin、Bradley V. Clineschmidt、David E. McClure、George F. Lundell、William C. Randall、Gregory E. Martin、Michael Williams
DOI:10.1021/jm00378a014
日期:1984.12
A series of tricyclic oxazines, namely, the 4-substituted 2H-naphth[1,2-b]-1,4-oxazines, have been synthesized and assayed for dopamine agonist activity. One of the members of this series, compound (+)VII-15, was found to be a remarkably potent agonist in vivo when tested in the standard 6-hydroxydopamine lesioned rat assay. The absolute configuration of the compound corresponds to that found in the active isomer of apomorphine. Its activity at the alpha 2 receptor (vs. [3H]clonidine) is relatively low. It also failed to stimulate the synthesis of cAMP in the carp retina assay, thus giving the compound a highly selective profile in favor of the D2 receptor.
DYKSTRA, D.;HAZELHOFF, B.;MULDER, T. B. A.;VRIES, J. B. DE;WYNBERG, H.;HO+, EUR. J. MED. CHEM., 1985, 20, N 3, 247-250
作者:DYKSTRA, D.、HAZELHOFF, B.、MULDER, T. B. A.、VRIES, J. B. DE、WYNBERG, H.、HO+
DOI:——
日期:——
MELILLO, DAVID G.;LARSEN, ROBERT D.;MATHRE, DAVID J.;SHUKIS, WILLIAM F.;W+, J. ORG. CHEM., 52,(1987) N 23, 5143-5150
作者:MELILLO, DAVID G.、LARSEN, ROBERT D.、MATHRE, DAVID J.、SHUKIS, WILLIAM F.、W+